Delta Cargo has approved the use of the DoKaSch Opticooler RAP container as part of its cold chain pharma service.
The approval comes as the air cargo industry prepares for the widespread transportation and distribution of Covid-19 vaccines.
Key features of the DoKaSch Opticooler RAP container include: temperature ranges of 2-8°C and 15-25°C, which enable it to be used for the transportation of Pharma 1 goods without dry ice; a large loading compartment that accommodates five standard Euro pallets or four CP-1 pallets; a battery that requires two to four hours of charging time, operational times of up to 120 hours; and a large control panel plus quadruple redundancy for all critical parts, which help to ensure “backups for each feature in case of failure”.
Shawn Cole, Delta’s vice president of cargo, commented: “The introduction of the Opticooler provides our customers with more choice when looking for reliable container options to support the growing global demand for pharma and vaccine shipments.”
“Alongside our joint venture partners, Air France-KLM Cargo, we can now offer our customers a seamless experience across the trans-Atlantic, helping to keep supply chains moving and ensuring the safe delivery of temperature sensitive shipments during the current pandemic.”
Andreas Seitz, managing director at DoKaSch Temperature Solutions, added: “This agreement with Delta provides more transport options for shippers of sensitive pharmaceutical goods, which is especially important for the upcoming transport of vaccines against Covid-19. Many of these will require a temperature range between 2°C and 8°C during transport, which is exactly what our Opticooler is made for.”
He added: “Delta further expands our extensive global network which allows us to offer our temperature-controlled packaging solutions at even more locations.”
Additionally, the carrier — which was the first US passenger carrier to receive the IATA CEIV Pharma certification — has expanded its cooler facilities at its Atlanta warehouse.
Recent Comments